NCT06362915

Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study)

Ain Shams University·Phase 1/2·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Anesthesia, Local
Drug/Device/Intervention
Lidocaine
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Ain Shams University
Location
Cairo,Cairo, Egypt
Timeline & enrollment
Phase
Phase 1/2
Start date
Jan 02, 2024
End date
Aug 30, 2024
Enrollment
52 participants
Primary outcome

Extra Demand of sedation

Summary

The purpose of the study is to compare the effect of illiohypogastric and ilioinguinal nerve
 block with the local infiltration with lidocaine in patients undergoing TAVI

ICD-10 classifications
Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362915
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06362915 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Anesthesia, Local. Target enrollment is 52 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.